Select a medication above to begin.
moosebeere
cranberry (Vaccinium spp.)
Entire Monograph
Reported Uses
- NOTE: see Herb & Supplement Effectiveness Rating Definitions table
- age-related cognitive decline [Insufficient Evidence]
- BPH [Insufficient Evidence]
- cancer [Insufficient Evidence]
- cardiovascular dz prevention [Insufficient Evidence]
- chronic fatigue syndrome [Insufficient Evidence]
- cystitis prevention, radiation-induced [Insufficient Evidence]
- diabetes mellitus, type 2 [Insufficient Evidence]
- H. pylori infection [Insufficient Evidence]
- hyperlipidemia [Insufficient Evidence]
- infection, catheter-related [Insufficient Evidence]
- memory [Insufficient Evidence]
- metabolic syndrome [Insufficient Evidence]
- nephrolithiasis [Insufficient Evidence]
- nonalcoholic fatty liver dz [Insufficient Evidence]
- obesity [Insufficient Evidence]
- overactive bladder [Insufficient Evidence]
- periodontitis [Insufficient Evidence]
- peristomal lesion [Insufficient Evidence]
- prostate CA prevention [Insufficient Evidence]
- rheumatoid arthritis [Insufficient Evidence]
- URI [Insufficient Evidence]
- urinary deodorizer [Insufficient Evidence]
- UTI prevention [Possibly Effective]
Reported Doses
Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies w/ variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely
Effectiveness Ratings
- [see Herb & Supplement Effectiveness Rating Definitions table]
age-related cognitive decline
- [Insufficient Evidence]
- Dose: 4.5 g PO bid
BPH
- [Insufficient Evidence]
- Dose: 500 mg PO tid; Alt: 250-500 mg PO qd
cardiovascular dz prevention
- [Insufficient Evidence]
- Dose: 500 mL/day (27% cranberry) juice PO divided qd-bid
cystitis prevention, radiation-induced
- [Insufficient Evidence]
- Dose: 200 mg PO qd
H. pylori infection, adult pts
- [Insufficient Evidence]
- Dose: 480-500 mL/day juice PO divided bid; Alt: 250 mL juice PO qd; Info: used w/ or w/o standard tx
H. pylori infection, peds pts
- [Insufficient Evidence]
- Dose: 200 mL juice PO qd; Info: for pts 6-16 yo; used w/ lactobacillus johnsonii
hyperlipidemia
- [Insufficient Evidence]
- Dose: 300 mL juice PO qd; Info: juice containing 25:15:10:50 chokeberry:blueberry:cranberry:apple ratio
metabolic syndrome
- [Insufficient Evidence]
- Dose: 240 mL juice PO bid
nephrolithiasis
- [Insufficient Evidence]
- Dose: 500 mL juice PO qd; Info: dilute w/ 1500 mL water
nonalcoholic fatty liver dz
- [Insufficient Evidence]
- Dose: 144 mg PO qd
overactive bladder
- [Insufficient Evidence]
- Dose: 500 mg PO qd
periodontitis
- [Insufficient Evidence]
- Dose: apply 2.5 g extract gel topically x1 after scaling and root planing; Info: used w/ garcinia
prostate CA prevention
- [Insufficient Evidence]
- Dose: 1500 mg PO qd
rheumatoid arthritis
- [Insufficient Evidence]
- Dose: 250 mL juice PO bid; Info: used w/ fish oil
URI
- [Insufficient Evidence]
- Dose: 450 mL juice PO qd
urinary deodorizer
- [Insufficient Evidence]
- Dose: up to 237 mL juice PO tid
UTI prevention, adult pts
- [Possibly Effective]
- Dose: 120-1600 mg/day PO divided qd-bid; Alt: 50-1000 mL/day juice PO divided qd-qid
UTI prevention, peds pts
- [Possibly Effective]
- Dose: 5 mL/kg/day juice PO divided qd-bid; Alt: 50 mL juice PO qd; 0.2 mL/kg/dose syrup PO qd; 100 mL 50% concentrate PO qd; 120 mg PO qd in pts 12-18 yo
Copyright © 2024. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.